MD Anderson Events
Ethics Seminar Series: The 'Myriad' Dilemma: Should We Be Able To Patent Our Genes?
The session will consider how healthcare professionals sometimes encounter ethical challenges in their practice. These individuals will gain insight into the current debate involving the nexus between the drive to provide innovative therapies and better patient outcomes with the incentives for health care entrepreneurship and remuneration. At the core of this intellectual property policy debate is the impact and reliance we have on technology/diagnostics as well as the fundamental question of "do we own our bodies?" This presentation will explore some of these issues and open a discussion to address them for social workers, physicians, nurses and ethicists.
Date: 6/11/13, 12pm to 1pm
Time: 6/11/13, 12pm to 1pm
Directions: Pickens Academic Tower
CME: The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit TM
Facilitator: Jessica A. Moore, DHCE
Speaker: Jeff Farroni, PhD, JD
Contact: Brittany Campbell - (713) 794-1495 - firstname.lastname@example.org
Ethics Seminar Announcment_ June 2013.pdf (PDF, 518 KB)
- S2M Science to Medicine Seminar "From cancer vulnerabilities to cancer therapeutics"
- Responsible Conduct of Research (RCR): Conflict of Interest and Commitment
- Thoracic, Head and Neck Cancer Research Seminar
- S2M Science to Medicine “Decoding of Network Attacking Mutations Rewiring Cancer”
- Fast Track Orientation
- BTC Distinguished Lecture Series
- Cancer Prevention Summer Trainee Exposition
- Responsible Conduct of Research (RCR): Collaborative Science
- MD Anderson Summer Experience Final Event
- S2M Science to Medicine Seminar Series - “Genetic and nongenetic determinants of single-cell programs in human gliomas”